Home » Events and News » Upcoming & Past

Events and News

May, 2018

Download der Antragsunterlagen:

  1. Vollständiger Ausschreibungstext
  2. Antragsformular
  3. Beschreibung des Projekts
  4. Betreuungs- und Qualifizierungskonzept
  5. Lebenslauf und Publikationsliste
  6. Kostenplan

NEU:Die Einreichfrist für Projektanträge ist am 3.08.2018 abgelaufen!

May, 2018

Congratulations to Dr. Robert Lukowski who was appointed as Full Professor of Experimental Pharmacology in the Pharmacology, Toxicology and Clinical Pharmacy Department at the University of Tübingen. His research focuses on the impact of cGMP pathway modulation and Ca2+/Na+-activated K+ channels such as BK and Slo2.2/Slack in animal models of disease and their utility in drug discovery applications. Since 2013 he acts as training coordinator and speaker of ICEPHA´s Graduate Program and as a board member of the DFG Research Unit “cGMP Signaling in Cell Growth and Survival” (FOR 2060).

To learn more about Robert Lukowski follow the link to the Experimental Pharmacology group at the Institute of Pharmacy.

 

February, 2018

ICEPHA´s speakers Prof. Laufer and Prof. Schwab, together with other renowned experts, contribute with their unique know-how, techniques and tools to the division of "Therapy Design" within the University of Tübingen framework of the Excellence Initiative. Find more information about "Therapy Design" within platform one of the University´s Excellence Initiative on personalised medicine.             

February, 2018

The ICEPHA has established a preferred partnership with the Tübingen Center for Academic Drug Discovery & Development (TüCAD2). Together with this academic platform we will optimize the development of potential drug candidates and their utility for clinical application. To learn more about TüCAD2, its members and projects please follow the link to the University´s Excellence Initiative.

January, 2018

Second call for the ICEPHA Graduate Program (more information will follow in April 2018).

December, 2017

The ICEPHA secured funding for the ICEPHA Graduate Program. We are very thankful for the ongoing support by the Robert Bosch Stiftung, the Medical Faculty of the University of Tübingen, and the University of Tübingen, which enables us to continue our commitment to pursue a successful and excellent doctoral training. 

PHOENIX Pharmaceutics Science Award 2017

The renowned award recognizes unique achievements in the pharmaceutical science field. Stefan Laufer was honored as one of the prize winners of this year for his work in the discipline of pharmaceutical chemistry. Congratulations to the winner!

If you want to know more about Stefan Laufer and the award follow this link to the PHOENIX group.

 

2nd Symposium of the ICEPHA Graduate School

26th October 2016

1:00 PM to 6:00 PM

 

Location

Robert-Bosch-Krankenhaus

Auerbachstr. 110

Raum E108 (Atrium 1)

70376 Stuttgart

Dr. Robert Pfleger Research Prize 2016 to Matthias Schwab

Matthias Schwab received this prestigious award for his innovative approaches to improve safety and efficacy of patient care using individualized drug regimens. An in-depth appreciation of his work is available at the official website of the Dr. Robert Pfleger Foundation.

 

1st Internal Symposium of the ICEPHA Graduate School

27th March 2015

1:00 PM to 6:00 PM

 

Location

Hörsaal 7E02

Hörsaalzentrum der Universität Tübingen

Auf der Morgenstelle 8

72076 Tübingen

ICEPHA Symposium on the Pathophysiology of Type 2 Diabetes

22th September 2014

8:00 AM to 6:00 PM

 

Location

Hörsaal N1

Hörsaalzentrum der Universität Tübingen

Auf der Morgenstelle 16

72076 Tübingen

Summer school: Tracking fast signalling processes in vivo

18th - 20th July 2014

ICEPHA PIs joined the Summer School "Tracking fast signalling processes in vivo – mechanisms, targets and tools" at the Benediktinerinnen-Abtei auf Frauenchiemsee. This Summer School was supported by the Excellence Initiative of the University of Tubingen. 


The new ICEPHA Graduate Program has been launched

July 2014

 

The ICEPHA Core members have approved the establishment of the Graduate Program Membrane-associated Drug Targets in Personalized Cancer Medicine. For an initial period of 3 years more than 20 PIs from Tübingen and the Campus of the Robert-Bosch-Hospital in Stuttgart will work together on 8 cutting-edge projects. We wish you all good success in your work.